Pennington, NJ, United States of America

Xia Han

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Somerset, NJ (US) (2009)
  • Pennington, NJ (US) (2009 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xia Han

Introduction

Xia Han is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. With a total of 3 patents, his work focuses on identifying biomarkers and methods that enhance therapeutic responses in cancer patients.

Latest Patents

One of Xia Han's latest patents is titled "Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators." This invention involves IGF1R biomarkers that are useful in identifying and monitoring mammals that will respond therapeutically to cancer treatments involving IGF1R modulators. The method includes exposing the mammal to the modulator and measuring the levels of specific biomarkers to determine therapeutic responses.

Another significant patent is "Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells." This invention describes polynucleotides that correlate with the sensitivity or resistance of breast cell lines to treatments involving protein tyrosine kinases. These polynucleotides serve as valuable tools for predicting drug responses and can act as prognostic or diagnostic indicators in disease management, particularly in breast cancer.

Career Highlights

Xia Han is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in cancer therapeutics. His work has been instrumental in developing innovative approaches to improve treatment outcomes for patients.

Collaborations

Xia collaborates with several esteemed colleagues, including Fei Huang and Karen A Reeves, who contribute to his research efforts and enhance the impact of his inventions.

Conclusion

Xia Han's innovative work in identifying biomarkers and developing methods for cancer treatment showcases his dedication to improving patient outcomes. His contributions to the field are significant and continue to influence cancer research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…